Global Regenerative Medicine Market Research Report - Industry Analysis and Forecast To 2018
- ID:PD000422
- October 2018
- Value Market Research
Single User License: $3,950.00
Multi User License: $4,950.00
Enterprise License: $8,000.00
The global regenerative medicine market was estimated to be at ~$4.5 billion in 2013.
A number of factors such as increasing bone related disorders, increasing use of nanograft products by physicians, technological advancements, shortage of organs available for donation and high organ transplant rejection rate, advancement in nanotechnology research, increasing corporate and federal funding, and increasing contract manufacturing organizations are driving the growth of global regenerative medicine market. However, presence of alternative technologies, and high cost of the treatment are restraining the growth of this market. Furthermore, the factors such as, emerging nations such as India, and China, and reimbursement policies for regenerative medicine can create opportunities for this market in coming years.
On the basis of segments, regenerative medicine market is divided into; stem cell therapy, gene therapy, phases of clinical trials, tissue engineering, and small molecules and biologics.
On the basis of products the market is majorly divided into, cell therapy (CT) based products, tissue engineered (TE) products, bone and cartilage grafting and regenerative products, and electrical stimulators.
Based on the applications, the market is segmented into: bone and joints replacement, dental applications, neurologic applications, organ regeneration, applications in cardiovascular disorders, applications in urologic disorders and diabetes, and wound care.
Further, on the basis of geography the market is divided into, North America, Europe, Asia-Pacific, and Rest of the World (RoW).
Aastrom Biosciences, Inc., Advanced Cell Technology, Athersys, Inc., Amgen Inc., Bioheart, Inc., Cytori Therapeutics Inc., Celgene Corporation, Geron Corporation, Genzyme Corporation, Osiris Therapeutics, Inc., Japan Tissue Engineering Co., Ltd., ThermoGenesis Corp. are the key players of global regenerative medicine market.
Decision Databases is involved in providing research reports and company profiles in the global regenerative medicine market in terms of revenue and output/volume. Market drivers, opportunities and restraints are thoroughly studied which influences the market. This study is further utilized for the overall analysis of the market. The regenerative medicine market is segmented based on the global applications, geographic presence, by products and ingredients. We offer an inclusive category-specific market outlook. We provide access to a comprehensive collection of companies in the industry. The companies can strategize and execute business operations through our competitor analysis. Find the global industry analysis, market size, share, growth, and trends information in our regenerative medicine profiles.
A number of factors such as increasing bone related disorders, increasing use of nanograft products by physicians, technological advancements, shortage of organs available for donation and high organ transplant rejection rate, advancement in nanotechnology research, increasing corporate and federal funding, and increasing contract manufacturing organizations are driving the growth of global regenerative medicine market. However, presence of alternative technologies, and high cost of the treatment are restraining the growth of this market. Furthermore, the factors such as, emerging nations such as India, and China, and reimbursement policies for regenerative medicine can create opportunities for this market in coming years.
On the basis of segments, regenerative medicine market is divided into; stem cell therapy, gene therapy, phases of clinical trials, tissue engineering, and small molecules and biologics.
On the basis of products the market is majorly divided into, cell therapy (CT) based products, tissue engineered (TE) products, bone and cartilage grafting and regenerative products, and electrical stimulators.
Based on the applications, the market is segmented into: bone and joints replacement, dental applications, neurologic applications, organ regeneration, applications in cardiovascular disorders, applications in urologic disorders and diabetes, and wound care.
Further, on the basis of geography the market is divided into, North America, Europe, Asia-Pacific, and Rest of the World (RoW).
Aastrom Biosciences, Inc., Advanced Cell Technology, Athersys, Inc., Amgen Inc., Bioheart, Inc., Cytori Therapeutics Inc., Celgene Corporation, Geron Corporation, Genzyme Corporation, Osiris Therapeutics, Inc., Japan Tissue Engineering Co., Ltd., ThermoGenesis Corp. are the key players of global regenerative medicine market.
Decision Databases is involved in providing research reports and company profiles in the global regenerative medicine market in terms of revenue and output/volume. Market drivers, opportunities and restraints are thoroughly studied which influences the market. This study is further utilized for the overall analysis of the market. The regenerative medicine market is segmented based on the global applications, geographic presence, by products and ingredients. We offer an inclusive category-specific market outlook. We provide access to a comprehensive collection of companies in the industry. The companies can strategize and execute business operations through our competitor analysis. Find the global industry analysis, market size, share, growth, and trends information in our regenerative medicine profiles.
1 Introduction
1.1 Overview
1.2 Objective Of The Study
1.3 Markets Definition And Scope Of The Study
1.3.1 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size
1.5.2 Market Share
1.5.3 Key Data Points From Secondary Sources
1.5.4 Key Data Points From Primary Sources
1.6 Auxiliary Factors
1.7 Assumptions
1.8 List Of Acronyms
2 Excutive Summary
3 Market Overview
3.1 Drivers
3.1.1 Increase In Bone Related Diseases And Disorders Primarily Drives The Market Growth
3.1.2 Increasing Use Of Non-Autograft Products By Physicians Is Driving The Growth Of Regenerative Medicine’s Market
3.1.3 Technological Advancements Stimulating The Market Growth
3.1.4 Shortage Of Organs Available For Donation And High Organ Transplant Rejection Rates Are Driving The Growth Of Global Regenerative Market
3.1.5 Advancements In Nanotechnology Research To Drive Market Growth
3.1.6 Increase In Corporate And Federal Funding Helped To Drive The Growth Of The Market
3.1.7 Increasing Contract Manufacturing Organizations Supports The Growth Of This Market
3.2 Restraints
3.2.1 Presence Of Alternative Technologies Hampers The Market Growth
3.2.2 High Cost Of The Treatment Is Restraining The Market Growth
3.3 Opportunities
3.3.1 Emerging Nations Such As India, And China Are Creating New Verticles For Regenative Medicines
3.3.2 Reimbursement Policies For Regenerative Medicine Creat New Opportunities For This Market In Coming Years
3.4 Supporing Data
3.4.1 Healthcare Expenditure
4 Global Regenerative Medicine Market, By Segments
4.1 Stem Cell Therapy
4.2 Gene Therapy
4.3 Phases Of Clinical Trials
4.4 Tissue Engineering
4.5 Small Molecules And Biologics
5 Global Regenerative Medicine Ma ...
1.1 Overview
1.2 Objective Of The Study
1.3 Markets Definition And Scope Of The Study
1.3.1 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size
1.5.2 Market Share
1.5.3 Key Data Points From Secondary Sources
1.5.4 Key Data Points From Primary Sources
1.6 Auxiliary Factors
1.7 Assumptions
1.8 List Of Acronyms
2 Excutive Summary
3 Market Overview
3.1 Drivers
3.1.1 Increase In Bone Related Diseases And Disorders Primarily Drives The Market Growth
3.1.2 Increasing Use Of Non-Autograft Products By Physicians Is Driving The Growth Of Regenerative Medicine’s Market
3.1.3 Technological Advancements Stimulating The Market Growth
3.1.4 Shortage Of Organs Available For Donation And High Organ Transplant Rejection Rates Are Driving The Growth Of Global Regenerative Market
3.1.5 Advancements In Nanotechnology Research To Drive Market Growth
3.1.6 Increase In Corporate And Federal Funding Helped To Drive The Growth Of The Market
3.1.7 Increasing Contract Manufacturing Organizations Supports The Growth Of This Market
3.2 Restraints
3.2.1 Presence Of Alternative Technologies Hampers The Market Growth
3.2.2 High Cost Of The Treatment Is Restraining The Market Growth
3.3 Opportunities
3.3.1 Emerging Nations Such As India, And China Are Creating New Verticles For Regenative Medicines
3.3.2 Reimbursement Policies For Regenerative Medicine Creat New Opportunities For This Market In Coming Years
3.4 Supporing Data
3.4.1 Healthcare Expenditure
4 Global Regenerative Medicine Market, By Segments
4.1 Stem Cell Therapy
4.2 Gene Therapy
4.3 Phases Of Clinical Trials
4.4 Tissue Engineering
4.5 Small Molecules And Biologics
5 Global Regenerative Medicine Ma ...
Related Categories :
Pharmaceuticals
www.decisiondatabases.com is a online aggregator of market and research database which includes databases, reports and profiles. We have started this portal with a aim to become one stop shop provider for marketing and research data requirements for various sector and country databases.
Main Categories
